BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29773143)

  • 1. Sex and vaccination: Insights from female rats vaccinated with juvenile-specific proteases from Fasciola hepatica.
    Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
    Vet Parasitol; 2018 May; 255():91-96. PubMed ID: 29773143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against Fasciola hepatica using cathepsin L3 and B3 proteases delivered alone or in combination.
    Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
    Vet Parasitol; 2018 Jan; 250():15-21. PubMed ID: 29329618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against fasciolosis by a multivalent vaccine of stage-specific antigens.
    Jayaraj R; Piedrafita D; Dynon K; Grams R; Spithill TW; Smooker PM
    Vet Parasitol; 2009 Mar; 160(3-4):230-6. PubMed ID: 19081192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of a formulation containing stage-specific recombinant proteins of Fasciola hepatica cathepsin L5 and cathepsin B2 triggers an anti-fecundity effect and an adjuvant-mediated reduction in fluke burden in sheep.
    Norbury LJ; Basałaj K; Zawistowska-Deniziak A; Sielicka A; Wilkowski P; Wesołowska A; Smooker PM; Wędrychowicz H
    Vet Parasitol; 2018 Jul; 258():14-23. PubMed ID: 30105973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
    Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
    Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep.
    Villa-Mancera A; Olivares-Pérez J; Olmedo-Juárez A; Reynoso-Palomar A
    Vet Parasitol; 2021 Jan; 289():109340. PubMed ID: 33373968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and differential expression of cathepsin L3 alleles from Fasciola hepatica.
    Zawistowska-Deniziak A; Wasyl K; Norbury LJ; Wesołowska A; Bień J; Grodzik M; Wiśniewski M; Bąska P; Wędrychowicz H
    Mol Biochem Parasitol; 2013 Jul; 190(1):27-37. PubMed ID: 23770026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of protective peptides of Fasciola hepatica-derived cathepsin L1 (FhCL1) in vaccinated sheep by a linear B-cell epitope mapping approach.
    Buffoni L; Garza-Cuartero L; Pérez-Caballero R; Zafra R; Javier Martínez-Moreno F; Molina-Hernández V; Pérez J; Martínez-Moreno Á; Mulcahy G
    Parasit Vectors; 2020 Jul; 13(1):390. PubMed ID: 32736582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses in rats and sheep induced by a DNA vaccine containing the phosphoglycerate kinase gene of Fasciola hepatica and liver fluke infection.
    Wesołowska A; Zawistowska-Deniziak A; Norbury LJ; Wilkowski P; Januszkiewicz K; Pyziel AM; Zygner W; Wędrychowicz H
    Acta Parasitol; 2016 Mar; 61(2):212-20. PubMed ID: 27078643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica.
    Villa-Mancera A; Alcalá-Canto Y; Reynoso-Palomar A; Olmedo-Juárez A; Olivares-Pérez J
    Parasitol Int; 2021 Aug; 83():102355. PubMed ID: 33872793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic activity in Fasciola hepatica is reduced by the administration of cathepsin L mimotopes.
    Villa-Mancera A; Quiroz-Romero H; Correa D; Alonso RA
    J Helminthol; 2011 Mar; 85(1):51-5. PubMed ID: 20416126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica.
    Mulcahy G; O'Connor F; McGonigle S; Dowd A; Clery DG; Andrews SJ; Dalton JP
    Vaccine; 1998; 16(9-10):932-9. PubMed ID: 9682340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine potential of recombinant pro- and mature cathepsinL1 against fasciolosis gigantica in mice.
    Kueakhai P; Changklungmoa N; Chaichanasak P; Jaikua W; Itagaki T; Sobhon P
    Acta Trop; 2015 Oct; 150():71-8. PubMed ID: 26116785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.
    Kesik-Brodacka M; Lipiec A; Kozak Ljunggren M; Jedlina L; Miedzinska K; Mikolajczak M; Plucienniczak A; Legocki AB; Wedrychowicz H
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005451. PubMed ID: 28333957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the immune response of male and female rats vaccinated with cDNA encoding a cysteine proteinase of Fasciola hepatica (FhPcW1).
    Wesołowska A; Norbury LJ; Januszkiewicz K; Jedlina L; Jaros S; Zawistowska-Deniziak A; Zygner W; Wędrychowicz H
    Acta Parasitol; 2013 Jun; 58(2):198-206. PubMed ID: 23666656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and expression of the major secreted cathepsin B-like protein from juvenile Fasciola hepatica and analysis of immunogenicity following liver fluke infection.
    Law RH; Smooker PM; Irving JA; Piedrafita D; Ponting R; Kennedy NJ; Whisstock JC; Pike RN; Spithill TW
    Infect Immun; 2003 Dec; 71(12):6921-32. PubMed ID: 14638781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel Fasciola hepatica cathepsin L protease containing protective epitopes within the propeptide.
    Harmsen MM; Cornelissen JB; Buijs HE; Boersma WJ; Jeurissen SH; van Milligen FJ
    Int J Parasitol; 2004 May; 34(6):675-82. PubMed ID: 15111089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the Fasciola hepatica newly excysted juvenile cathepsin L3 (FhCL3) by its propeptide: a proposed 'clamp-like' mechanism of binding and inhibition.
    Pritsch IC; Tikhonova IG; Jewhurst HL; Drysdale O; Cwiklinski K; Molento MB; Dalton JP; Verissimo CM
    BMC Mol Cell Biol; 2020 Dec; 21(1):90. PubMed ID: 33287692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasciola hepatica: studies on vaccination of rats and mice with a surface antigen prepared from fluke homogenate by means of a monoclonal antibody.
    Hanna RE; Anderson A; Trudgett AG
    Res Vet Sci; 1988 Mar; 44(2):237-41. PubMed ID: 3291030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.